Loading insider details...
Beta
Latest Form 4 (Feb 5, 2026): Grant/Award of 3,000,000 SABS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 5, 2026 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 3,000,000 | n/a |
| Aug 28, 2025 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 3,000,000 | n/a |
| Jul 17, 2024 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 46,528 | n/a |
| Feb 23, 2024 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 190,000 | n/a |
| Dec 8, 2023 | SAB Biotherapeutics, Inc. (SABS) | Purchase | 1,740 | $1.5K |
| Mar 16, 2023 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 525,000 | n/a |
| Sep 15, 2022 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 35,000 | n/a |
| Sep 8, 2022 | SAB Biotherapeutics, Inc. (SABS) | Purchase | 14,000 | $10.3K |
| Mar 19, 2022 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 21,218 | n/a |
| Oct 27, 2021 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 5,213,764 | n/a |